Next Quarterly Earnings
Monday, November 16, 2026
CW 47
Pre-Market
In 81 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Viridian Therapeutics
Viridian Therapeutics is a leading U.S. biotechnology company specialized in developing innovative antibody therapies. The firm focuses on treating severe autoimmune diseases, with a particular emphasis on thyroid eye disease and other rare indications that require advanced therapeutic solutions.
Frequently asked questions
When will Viridian Therapeutics report its next quarterly earnings?
Viridian Therapeutics is scheduled to report its next quarterly earnings on 11/16/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did Viridian Therapeutics last report quarterly earnings?
Viridian Therapeutics last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -1.05 USD.
How often has Viridian Therapeutics beaten expectations?
Viridian Therapeutics has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
How do I add the Viridian Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
2/5
Quarters above estimates
40%
Beat rate
+3.2%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Viridian Therapeutics
Country
🇺🇸
More Financial Information